Abstract Background Group B Streptococcus (GBS) remains a leading cause of neonatal
sepsis in high-income contexts, despite declines due to intrapartum antibiotic prophylaxis …

Invasive disease due to group B Streptococcus infection (Streptococcus agalactiae) results
in a wide spectrum of clinical disease. In North America, serotypes Ia, Ib, II, III, and V are …

Importance Invasive disease owing to group BStreptococcus (GBS) remains an important
cause of illness and death among infants younger than 90 days in the United States, despite …

The incidence of neonatal early-onset sepsis (EOS) has declined substantially over the last
2 decades, primarily because of the implementation of evidence-based intrapartum …

In response to the ever-changing needs and responsibilities of the clinical microbiology
field, Clinical Microbiology Procedures Handbook, Fourth Edition has been extensively …

Importance Current algorithms for management of neonatal early-onset sepsis (EOS) result
in medical intervention for large numbers of uninfected infants. We developed multivariable …

Early-onset sepsis remains a common and serious problem for neonates, especially preterm
infants. Group B streptococcus (GBS) is the most common etiologic agent, while Escherichia …

Streptococcus agalactiae or group B streptococcus (GBS) is a leading cause of serious
neonatal infections. GBS is an opportunistic commensal constituting a part of the intestinal …

Early-onset sepsis (EOS) remains a serious and often fatal illness among infants born
preterm, particularly among newborn infants of the lowest gestational age. Currently, most …

Human milk oligosaccharides (HMOs) are a group of complex sugars that are highly
abundant in human milk, but currently not present in infant formula. More than a hundred …